Skip to main content

“No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia

Abstract

Background

Primary needle and syringe programs (NSPs) have been integral for the prevention of blood-borne virus (BBV) transmission among people who inject drugs. Despite this, many people who inject drugs face barriers accessing these services, particularly after-hours when most services are closed. To our knowledge, the St Kilda NSP, in Melbourne, Victoria, is the only primary NSP providing 24/7 dedicated stand-alone face-to-face services for people who inject drugs in Australia. We conducted an evaluation of the St Kilda NSP to assess its role and effectiveness in meeting client needs.

Methods

Mixed research methods were used to conduct the evaluation. We analysed four quantitative data sets including the Victorian Needle and Syringe Program Information System data; NSP ‘snapshot’ survey data; and St Kilda NSP records of after-hours contacts and naloxone training events. Qualitative interviews were conducted with 20 purposively selected NSP clients, which were focused on individual needs, expectations and experiences accessing the service. Interviews were audio recorded and transcribed, and data were analysed thematically. A convergent research design was used to merge the five data sets.

Results

St Kilda NSP had 39,898 service contacts in 2018; 72% of contacts occurred outside business hours. Similarly, of 1,185,000 sterile needles and syringes dispatched, 71% were distributed outside business hours. Participants described valuing the after-hours service because drug use patterns did not always align with standard NSP opening hours and after-hours access afforded anonymity when collecting injecting equipment. Narratives highlighted several additional benefits of the 24/7 service, including: access to safer sex equipment; material support; naloxone training; referrals to specialist services; face-to-face emotional and social support from a non-judging worker; and for women involved in sex work in particular, being able to seek refuge when feeling unsafe on the streets.

Conclusions

Our study provides evidence of the social and health benefits (beyond that of preventing BBV transmission) that can be gained through the provision of 24/7 primary NSP services. Findings support the need for the establishment of after-hours primary NSPs in other areas of Australia where active street-based drug markets operate outside business hours and concentrated numbers of people who inject drugs live and spend time.

Background

Needle and syringe programs (NSPs) have been providing harm reduction services for people who inject drugs in Australia for more than three decades [1], often cited as central in averting the HIV epidemic among this population group [2, 3].

Between 2020 and 2021 a network of more than four thousand NSPs were operating across Australia via a range of service models, distributing around 50.2 million sterile needles and syringes (herein referred to as needles/syringes) to people who inject drugs [4]. Over 100 primary NSPs provide stand-alone staffed specialist services, and approximately 800 secondary NSPs operate within existing health services (e.g. community health centres and hospitals) [4]. Some primary and secondary NSPs provide services via peer-to-peer distribution and mobile outreach services. Furthermore, needles/syringes are distributed at no cost or for a small fee via more than 2900 pharmacy NSPs and approximately 400 syringe dispensing machines (SDMs) [4].

Despite the widespread success of NSPs in averting the transmission of blood-borne viruses (BBVs) and other harms associated with injecting drugs [3, 5,6,7], many people who inject drugs continue to face challenges accessing needles/syringes [8,9,10,11,12]. Barriers accessing injecting equipment include: NSPs operating in inconvenient locations (e.g. too far to travel, poor public transport options); financial barriers accessing needles/syringes from pharmacies and SDMs; stigmatising service provider attitudes; and being unable to store sufficient quantities of syringes or carry them on their person (e.g. due to homelessness or fear of police harassment or surveillance) [8,9,10, 13]. An additional frequently cited barrier to accessing needles/syringes is that most government-funded primary NSPs are only open during weekday business hours, despite that injecting practices are not always planned and often occur outside these hours [2, 9, 11, 12]. For example, one Melbourne-based study found that of 584 participants who inject drugs, 23% of heroin use and 50% of methamphetamine use occurred outside of business hours, as did injecting for those who were currently employed [12]. Another study [9] found operating hours were the second most frequently reported perceived barrier for accessing NSPs (amongst a list of 16 barriers) for people who use drugs but never or infrequently used NSPs, with 57% of infrequent NSP users reporting operating hours as a barrier to access.

It is well established that SDMs address many of the barriers identified above, including enhancing geographical reach in areas of low NSP coverage, affording people privacy and anonymity when accessing needles/syringes, and increasing after-hours access to needles/syringes when fixed site secondary and primary NSPs are closed [7, 14,15,16]. For example, the study of SDMs in Melbourne between 2017 and 2020 cited above found 69% of 90,488 unique SDM presentations occurred out of NSP operating hours [17]. Similarly, two studies of SDM use in Sydney found over half the participants used the SDM outside of business hours with usage peaking on weekends [11, 13].

Nonetheless, studies have also found that SDMs are sometimes broken, jammed or empty [13, 18] and, when they do work, they cannot address the accompanying co-occurring health and well-being needs experienced by people who inject drugs [19,20,21,22,23]. Primary NSPs, on the other hand, which are funded to provide targeted face-to-face services by dedicated NSP staff, usually have the capacity to provide people who inject drugs with this additional support, including referrals to other appropriate agencies for specific presenting needs. Furthermore, primary NSPs are often a first point of contact with the health system for stigmatised populations of people who inject drugs [8, 19,20,21,22], and yet most are only open during business hours ), limiting access.

To our knowledge, the St Kilda NSP is the only primary NSP that provides 24/7 face-to-face services in Australia. In 2018, the Salvation Army commissioned the Burnet Institute to conduct an evaluation of the 24-h NSP, to determine its role and effectiveness, in the context of an application for funding to maintain the 24/7 staffed model [24]. In the following, we present findings of this evaluation, with the aim of describing what were assessed to be the multi-faceted benefits such a service can provide for people who inject drugs. To provide context, we describe the St Kilda NSP and its geographical location, followed by the methods used to collect and analyse data, the research sample, and results. We conclude with a discussion of the implications of our analysis.

Research setting and context

St. Kilda, where the 24/7 NSP is located, is a suburb approximately 6 km south of the Central Business District of Melbourne. Between the 1950s and 1990s the area was characterised by deteriorated building stock, active street drug trades, sex work and homelessness [25, 26]. The process of gentrification and urban redevelopment began around three decades ago, leading to rising property values and an associated decline in low-cost accommodation [26]. Anecdotally, these changes have led to increased pressure on low-income and disadvantaged residents—including people who use drugs, people experiencing homelessness and people involved in sex work—which has resulted in increased demand for health and community services to meet their needs. To our knowledge, no published data exist about gentrification-induced displacement in St Kilda; however, studies in other geographical locations have found links between gentrification, unstable housing, and homelessness [27, 28]. Furthermore, anecdotal evidence suggests ongoing gentrification in St Kilda has driven a smaller low-cost rental market and contributed to the closure of high-volume low-cost rooming houses (such as the Gatwick Hotel [29]), potentially increasing housing instability and homeless in the area. Despite this gentrification, a significant street-based drug market and street-based sex industry continue to exist in St Kilda.

The St Kilda primary NSP was one of the first government-funded fixed site primary NSPs in Australia. Established in March 1991 amidst a growing concern about the spread of BBVs, particularly HIV/AIDS, the NSP was immediately well utilised, providing over 8000 needles/syringes in the first month of its operation [30]. The service was co-located with The Salvation Army’s Crisis Contact Centre in St Kilda and, at the time, relied solely on word of mouth to promote its existence. Following a successful proposal to the Victorian Government to expand the operating hours of the NSP, a 24/7 service delivery model was introduced in 2008. In 2024, the NSP continues to be staffed all day every day of the week, including on public holidays.

The NSP remains co-located within The Salvation Army’s Crisis Contact Centre, which operates a state-wide after-hours emergency accommodation response service (including housing advocacy, information, support, material aid and referral services for people experiencing or at risk of homelessness). The NSP is operationally managed by a specialist AOD harm reduction Primary Health Care service (Access Health), located in the building next door. Access Health is funded by the Victorian Government to provide a local Comprehensive Primary Health Care response to people who inject drugs and/or people who experience barriers accessing mainstream and specialist health services due to experiences of homelessness, interactions with the justice system or engagement in street-based sex work. The integrated service model consists of six organisations co-located under formal partnership agreements to provide a ‘one-stop-shop’ of accessible, flexible and non-judgemental health and specialist services. A range of other services are provided by Access Health, including BBV testing and treatment; harm reduction services (e.g. opioid agonist treatment, overdose education, free naloxone distribution and training); nursing services (e.g. pathology, wound care, outreach and general health); drug and alcohol intake, assessment and counselling services; forensic psychology; dental services; sexual health testing and treatment; chronic disease management; and services for Aboriginal and Torres Strait Islander Peoples. Primary functions of the NSP include providing sterile injecting equipment (including filters, swabs, disposal containers, tourniquets and mixing spoons); services for the disposal of used equipment; harm reduction information and education; safer sex equipment (SSE, e.g. condoms, dams, personal lubricant); and referral to specialist health and support services.

The NSP is overseen and led by an experienced senior social worker, and most NSP workers have a tertiary qualification or equivalent in a specific or related field, including social work, and alcohol and other drug counselling. Lived and living experience is held as a highly valued staff skill set. NSP workers receive on-the job training, including education about: drugs, drug use and harm reduction practices; the needs of the different cohorts accessing the service; and processes and services for referring clients. No external signage exists at the NSP, to enhance anonymity. A private space behind a closed door allows one client at a time to enter and engage with a NSP worker, which is designed for private individual one-on-one conversations, unless clients request and consent to enter in small groups (e.g. with friends, partners). Injecting equipment and most other resources (excluding SSE and safe disposal containers) are kept behind the counter, so clients must request what they need.

Methods

A mixed methods research design was used to conduct our study, with the aim of capitalising on the complementary strengths of both quantitative and qualitative methods [31], to provide a more comprehensive understanding of the role and effectiveness of the St Kilda NSP for individuals using the service.

The research was informed by an advisory group which included staff from the St Kilda NSP, Salvation Army senior staff, representatives from the Victorian Government and members of the research team. Ethics approval to conduct the study was granted by the Alfred Health Human Research Ethics Committee (Approval #501-18).

Quantitative study

Four quantitative data sets were used for our analysis. For the period 1 January 2018 to 31 December 2018, we sourced NSP Information System (NSPIS) data (n = 39,898), which routinely captures self-report demographic, harm reduction service activity and survey data of needle distribution and returns from NSPs across the state of Victoria [32]. At the time of data collection, St Kilda 24-h NSP counted needles distributed as the number of tips/needles distributed per service contact. Accordingly, a service contact which included distribution of 10 × 27-gauge syringes (needle tips and barrels) along with 10 × 19-gauge needle tips was recorded as 20 needles distributed. The same counting rules applied to needles returned to the NSP. NSPIS does not include data on the types of needles distributed/returned at each service contact.

We also used complementary NSP ‘snapshot’ survey data, which was sourced via a series of brief additional questions added to the St Kilda NSPIS administrative questionnaire for the purposes of the St Kilda evaluation; responses were captured during each service contact (n = 3218). Snapshot surveys were conducted in three brief periods between October and November 2018 (Snapshot Survey 1: 13:00 on 12/10/18 to 11:00 on 24/10/18; Snapshot Survey 2: 12:00 24/10/18 to 16:00 on 07/11/18; Snapshot 3: 16:00 07/11/18 to 12:00 on 14/11/18). Participants were questioned about the drug they last injected, with the remaining questions varying across surveys to capture information of interest to the evaluation, as detailed in Table 1. Additionally, the Salvation Army provided two records of additional activities of the NSP, including a record of additional after-hours services (5 pm–8:50 am) for the period between 1st July 2016 and 30th November 2018 and a record of naloxone training events (which included the distribution of vouchers to obtain naloxone, to training participants) for the period 1st February 2018 to 30th November 2018.

Table 1 Results of NSP snapshot surveys

Descriptive statistics were generated for quantitative variables relating to socio-demographics and experiences of substance use, health outcomes and service use. The numbers of needles/syringes and SSE distributed, and used needles returned, and client demographics were analysed by client gender and/or time of service use. Data analysis was conducted using Stata 16.1.

Qualitative study

Qualitative interviews were conducted with 20 clients of the NSP between October and November 2018. Participation was voluntary and involved informed consent. Interviews were guided by a semi-structured interview schedule focused on participants needs, expectations and experiences in relation to accessing the service, and any impact the service had had on their lives. Purposive sampling was used to ensure the inclusion of information-rich cases, including an intention to recruit at least some participants who had been accessing the service for at least five years.

Twelve women and eight men who used the NSP service participated in qualitative interviews; participants were aged between 28 and 61 years. Most described experiences of periods of homelessness, unemployment, poor mental health and ongoing challenges with drug use. A long history of attending the NSP was common for most participants, with some having attended the service since it first opened. Many participants resided in the local area or had done so in the past; others reported working in the area.

Interviews were audio recorded and transcribed, and data were managed using NVivo qualitative data software [33]. Data were analysed thematically using a coding framework. Extracts of transcripts were assigned to deductive codes based on topics within the interview schedule, and as new patterns, commonalities and discrepancies were identified, additional codes and sub-codes were inductively created to represent these themes [34]. All authors agreed upon four final themes. To increase the validity of our findings, we used a convergent mixed methods design to integrate the data [35]. The approach involved weaving the quantitative and qualitative data together into three of the four themes we identified (excluding “NSP client demographics and service use”, which only includes quantitative data).

Results

Results are presented together via four themes: 1) St Kilda NSP client demographics and service use; 2) Accessing needles/syringes after-hours; 3) Addressing women’s after-hours needs; and 4) More than a service for accessing needles/syringes.

To protect the identity of participants, quotes are followed by a unique identifier and the sex of the participant (i.e. P#, male/female).

St Kilda NSP client demographics and service use

In 2018, according to NSPIS data, 39,898 service contacts occurred for the NSP; most contacts were for males (73%), typically over 36 years of age (65%). Table 1 details characteristics of snapshot survey respondents, with data on last drug injected aggregated across all three snapshot surveys with the remaining variables unique to each survey. Snapshot survey data revealed approximately 11% of service contacts were for people who identified as Indigenous and 16% who identified as lesbian, gay, bisexual, transgender, queer or intersex (LGBTQI). Almost half (43%) stated that one or both parents were born outside Australia, almost half (46%) were unemployed, and around one in five were living in public housing (21%) or were homeless (18%).

According to snapshot survey data, methamphetamine was the most frequently injected substance (44%), followed by heroin (38%). People attending the service overnight were more likely to report recent methamphetamine injection. A small number of clients reported performance and image-enhancing drugs (e.g. steroids or melatonin) as their drug most recently injected.

Most NSP visits occurred outside of business hours (i.e. 09:00–16:59), with 19%, 19% and 32% of visits occurring during evening hours (17:00–22:59) late night hours (23:00–08:59), and weekends and public holidays, respectively. Times of presentation were similar across NSPIS data and snapshot survey data. Analyses of 2018 NSPIS data (see Table 2) found different patterns of service access according to sex, with 75% of visits by females occurring outside of business hours, compared to 69% for men (X2 [df = 1, n = 39,726] = 147.9527, p ≤ 0.001).

Table 2 Sex, number of sterile needles distributed, number of needles returned and visits including distribution of SSE by time of NSP visit between 1st January 2018 and 31 December 2018 (source: NSPIS)

Accessing needles/syringes after-hours

According to 2018 NSPIS data, most clients accessed the NSP to obtain injecting equipment. The NSP distributed a total of 1,185,000 needles during 2018; almost three quarters (71%) were distributed outside of business hours (see Table 2). Similarly, of the needles/syringes that were returned to the service (n = 484,516), 69% were returned outside of business hours. Seventy-five per cent of sterile needles were distributed to males who made up 71% of total service visits. Needles/syringes were mostly obtained from the NSP in amounts of five or less (44%), followed by 6–10 (25%) and 100+ (15%).

Many interview participants described valuing the after-hours nature of the NSP service for collecting injecting equipment because their drug use patterns did not always align with standard NSP opening hours (9–5 pm weekdays).

Well, no one does drugs just during business hours. It’s an impulse thing. (P3, male)

…like anyone who is a drug user, like we can prioritise […] but things can just go out of whack just like that, and all of a sudden at the drop of a hat, you’ll go “bang” and you’re off on a mission. Yeah, so it’s really hard to be scheduled and go, “okay it’s only open from 9 am until whatever”- it just doesn’t work like that. (P7, female)

For people who worked regular business hours (9 am–5 pm), being able to access needles/syringes after-hours was also considered an important factor.

It’s silly to think that people will just use or inject 9–5 pm. You know there’s a lot of people who like myself work full-time. I think people don’t realise that. I actually think it’s at night-time that it’s needed most. (P18, male).

Although some participants acknowledged that SDMs provided access to needles/syringes after-hours, they were described as empty on some occasions or required a fee to purchase items, which created access barriers.

[There’s] a vending machine closer for me [but] most of the time the free lot are gone, and the next lot cost a gold coin. But if the slot is full, you can’t get any. So, you risk not being able to get needles at all. (P6, female)

Mobile NSPs were raised by interview participants as an important service operating out of business hours, but as one participant highlighted, these services (in Melbourne) do not deliver injecting equipment past late evening hours.

There’s foot patrol (mobile NSP) but that has really strict hours as well – they don’t have the funding unfortunately, and sometimes you need to use outside of those hours. (P5, male)

One interviewee acknowledged his appreciation of the extended opening hours of the Melbourne Supervised Injecting Room, which he often visited to inject safely. He reflected, however, on how it was not open overnight and on weekends when he sometimes most needed to access needles/syringes.

Well, [the St Kilda NSP] is the only one apart from the safe injecting rooms - which I use … But as the night rolls in - I think it’s [open until] 7 pm on weekdays and 5 pm on the weekends – so a lot of times it’s not open when I need it. (P1, male)

Most participants viewed the 24-h operation of the NSP as vital to their ability to protect themselves from BBVs and other injecting-related injury and disease. In doing so, they expressed a sophisticated understanding of the ‘return on investment’ the 24-h NSP service can provide, by not being forced to reuse and/or share injecting equipment if the service was closed.

It’s because of night-time needle exchanges that I’m lucky enough not to be HIV positive. (P7, female)

Well, you don’t have to worry about using dodgy fits, so your health is protected. I don’t know where I’d go to get a ‘freshy’ [sterile needle/syringe] if this place wasn’t open. (P2, female)

One participant who had experienced periods of homelessness and sometimes injected drugs at night, described how when he was homeless the NSP was a saviour because he had no place to store boxes of needles/syringes.

I come all hours of the day and night - no specific times, just when I ‘get on’ [inject drugs]. When I've got a home, I tend to keep a box of ‘fit’s [needles/syringes] at home but when I’ve been homeless it’s been so helpful to [get them] after midnight or even after 5 pm. (P6, male)

Being able to collect injecting equipment anonymously, when “it was dark” and deemed less likely to be seen by on-lookers, was also acknowledged as a benefit of the NSP, especially for avoiding stigma and discrimination.

At night-time if you do like use and you want to be discreet about it, like you can be, but during the day people obviously know that you’re coming in and out – and then you constantly get labelled you know – “junkie”. (P9, female)

Addressing women’s after-hours needs

Women represented almost a third of all clients visiting the St Kilda NSP after business hours, with an increase overnight of 7% compared to access during business hours. Some of these women (including transgender women) worked in the sex industry and accessed the service for injecting equipment and/or SSE; however, many also used the service to seek refuge when feeling unsafe on the streets, to seek warmth in the winter months, or to access support from a non-judging worker.

Overall, females were more likely to visit the NSP for SSE collection than males in 2018; however, this varied significantly by the time of visit. Women accounted for 43% (n = 282) of SSE distributions during business hours, but most SSE distributions at all other times (see Fig. 1).

Fig. 1
figure 1

Visits including distribution of SSE* by time of visit between 1st January 2018 and 31 December 2018 (source: NSPIS)

People engaged in sex work described the importance of having free condoms available after-hours to maximise opportunities for safer sex while working.

If we couldn’t access free condoms, then there’d be girls having to do things they don’t want to do […] because a lot of the men won’t go and buy [condoms] because they can get sex without a condom, so you’re pretty much fucked. (P20, female)

With the NSP I mostly drop in around 10–11 pm at night or 3–4 am in the morning to get condoms - that’s when I tend to come out for night times, and usually at the end of a shift […] so middle of the night times. (P9, female)

Some women believed if the St Kilda NSP was not open overnight they would be forced to obtain SSE through illegal means.

Because we can get what we need we don’t need to steal like condoms and stuff. (P16, female)

When I first came to St Kilda and worked, if these guys weren’t here, I would’ve been in jail because I would’ve been stealing condoms and stuff, and it would have just tipped my criminal record over the edge. (P13, female)

Although the numbers of people engaged in sex work were not as high as some other groups accessing the NSP, the safety role it provided for this cohort (e.g. from male perpetrators of violence or males who posed a potential threat to their safety on the streets), was considered one of the critical aspects the service. For these reasons, the NSP was often described as a temporary refuge.

If you’re wary on someone, like if you’re out there and you’re on your own, and you can see a car you know … Like sometimes I get wary on someone, so I’ll just come in and I go, “I’m just gonna sit in here for five minutes”. (P20, female)

A lot of the working girls will run in there for sanctuary, sometimes because some predator will be stalking them. I know for me, on many occasions - cos I’m only little - quite often a couple of guys will see me and go, “Yeah, she’ll have stuff [illicit drugs] on her for sure, let’s get her, she’s on her own”. That’s a regular occurrence in St Kilda, a lot of full-on stand-overs! Yeah, this place is really a little sanctuary, but especially because it’s open 24/7. (P19, female)

The local street knowledge of NSP workers and access to the monthly “Ugly Mugs Report”Footnote 1, was considered highly valuable and appreciated by participants, especially for those who were engaged in sex work.

The workers know so much about what’s happening on the streets […] Yeah, the girls will go in and talk about what’s going on, so the workers will hear about ‘mugs’ [men often known to the police as posing a safety threat], or they’ll hear about gear, or they’ll hear about issues with cops and then they’ll pass that information on to us. So, it’s a really good touchstone for me. (P14, female)

A couple of participants described how they felt the attitude of some local police towards women engaged in sex work had improved because of the work of the NSP to educate police.

… the cops and the exchange and the girls, like everybody liaises - and the cops, because of this, I think [it has] kind-of changed their attitude towards us. Like our safety seems to be considered more important. (P11, female)

More than a service for accessing needle/syringes

Data collected by St Kilda NSP revealed a diverse range of services being delivered to clients after business hours (see Table 3). A total of 293 after-hours service contacts were responded to between July 2016 and December 2018, with 658 responses provided. The most common types of response were supportive chats or debriefs (n = 180), referrals to support services (n = 99), material support (n = 149) and basic medical assistance (n = 30). Just under 25% of responses were provided to clients experiencing violence, safety issues, mental health issues or who were victims of crime of various types. Most of these additional after-hours’ responses were provided to women (67%).

Table 3 Additional after-hours (evening, overnight and weekends) response frequencies 1st July 2016–30th November 2018 (source: after-hours log)

Although on-the-spot referrals to most services cannot be facilitated by the NSP overnight (due to the standard 9 am–5 pm operating hours of most services), for some clients, simply having the opportunity to obtain information about services was described as useful in leading to opportunities for referral in the future.

The hours really suit me. Just knowing that it is here and knowing that any question in this field that I don’t have an answer to, about where to go or what to do, I can get it even if it’s three in the morning. (P6, male)

Many participants described the importance of material support provided without judgement, such as blankets if they were homeless or engaged in street-based sex work, food if they faced financial challenges, or referrals to housing services.

They are more than just handing out needles […] I’ve been able to get things I’ve needed for drug use and condoms [and] a lot of the time they’ve had donations like bread or vegies - just little things like that. It doesn’t seem a lot, but when you have nothing, it means a lot. [...] They knew I’d spent my money on drugs and that’s why I needed vouchers for food, but they didn’t judge. (P7, female)

… that was why it was really useful - because disasters always happen at 3 in the morning. I wasn’t even thinking at the time that they were going to help me. They just asked me what was wrong, and instantly […] they are arranging somewhere for me to go [for the] night, something for me to eat. They were straight onto it. (P8, male)

In 2018, a total of 673 people were trained to respond to opioid overdoses, including how to administer naloxone; the majority (60%) of training participants were male. Half (50%) of this training was provided outside of business hours, a factor that was appreciated by clients who accessed the training overnight.

I did the naloxone training there one night, which has saved lives. You can’t get that 24 hour a day [anywhere else] (P4, male).

Several clients discussed experiencing significant social isolation. Contact with St Kilda NSP staff represented one of their few opportunities for human interaction, particularly after-hours. That these experiences were overwhelmingly positive and valued highly was evident in participants’ accounts.

You have this night-time population of people and I imagine it happens to women [not engaged in sex work] as well. Somewhere between 40–50 [years of age] they start becoming night people and so there is a lot of people just floating around in the night that don’t get enough contact with people. (P17, female)

… how are you supposed to talk to a vending machine, asking if you’re okay. It’s the human contact that you need. I’ve come in here a couple of times when nothing else has been open like when my dog died, and they were able to talk to me about it and they care. It would be devastating if this place wasn’t open (P20, female).

Some participants felt they owed their life to having been able to attend the St Kilda NSP after-hours when needed:

… there have been times when I’ve gone out and ‘scored’ [purchased drugs] with the intention of killing myself because my depression got so bad. I’d picked up syringes and I didn’t even tell them that that was my intention cos I didn’t want the burden of them knowing that. […] That small interaction of them understanding me and offering support … I went home and I didn’t overdose on purpose. I just used a small amount instead. That’s happened more than once. In a sense you could say I almost owe my life to these people without them even knowing it. (P3, male)

I wouldn’t be here telling you this story today if it wasn’t for [them]. It’s kept me alive. It’s kept me together. It’s just kept me putting one foot in front of the other. They really give a damn. They’re so selfless. (P14, female)

Highly valued by several participants was the confidential nature of visits to the NSP. The assurance they would be seen individually, could take as much time as they needed without interruption and could visit at times that were more discreet (e.g. after dark) was described as particularly important.

… because of the one person at a time, people don’t feel threatened [and] people don’t know what you’re getting, because quite often there’s so many people, or predators out there, and they’ll be like, “Ok, given what they’re picking up [needles], they’ve obviously got a lot of gear, you know, let’s follow these people”. (P6, male)

All participants who were interviewed, without exception, talked positively about the St Kilda NSP staff.

They’re incredible people [the NSP workers]. There’s no judgement, there’s no nothing. You walk through that door at four in the morning - it doesn’t matter what time it is - there’s a friendly face giving you exactly what you need, so there’s no need to share anymore, shit like that. It’s just a very important hub that place, and I couldn’t even imagine St Kilda functioning without it. (P7, female)

Discussion

Our evaluation of the St Kilda primary NSP suggests that there are significant social and health benefits that can be afforded through the provision of 24/7 services for people who inject drugs. Our analysis of client demographics highlights the substantial levels of disadvantage experienced by clients of the St Kilda NSP, and the services capacity to address equity of access for marginalised sub-populations of people who inject drugs, including Aboriginal and Torres Strait Islander Peoples, people who are experiencing homelessness and unemployment, people who identify as LGBTQI and people engaged in sex work. Moreover, given 71% of needles/syringes provided in 2018 were distributed outside of regular business hours, our findings demonstrate the critical need for access to injecting equipment when most other NSPs are closed [2, 4, 8, 9, 11, 15, 17, 36]. Client narratives support this, emphasising that injecting drug use does not always occur in standard opening hours, that injecting episodes are not always planned, and that for individuals who are experiencing homelessness and unable to store injecting equipment, that the 24/7 availability of individual needles/syringes is essential for their health and safety [37].

Many evaluations of NSP services have focused on understanding their effectiveness in preventing BBV transmission and related harms, for HIV and hepatitis C in particular [1, 5, 6, 21, 23, 38,39,40,41,42,43]. Our study has demonstrated that a primary 24/7 NSP can increase after-hours access to injecting equipment (for preventing BBV transmission) but can also increase after-hours access to a diverse range of additional health and social services. That is, although the service is limited in its capacity to provide immediate referrals overnight, our data highlight that after-hours access to crisis accommodation, material support and first aid are commonly provided and valued, as was the opportunity to participate in naloxone training overnight. Although most NSP service contacts were for the collection of injecting equipment and SSE, our findings suggest it also offers a place where clients can find refuge and support when no other services are available. Narratives highlight how the opportunity for human contact overnight with someone who cared and valued clients was highly regarded, especially for those who were experiencing homelessness or engaged in sex work, which was identified in large part due to the non-judgemental and welcoming attitudes of staff. Furthermore, qualitative findings highlight how the 24/7 operating hours of the NSP were able to accommodate client needs for anonymity by being able to access the service after-hours or when fewer people were around—a factor that helped avoid stigma.

Study findings also underscore the value of the 24/7 operating hours for women and people engaged in sex work. The fact that women constituted just over a quarter of service contacts yet made up almost a third of all night-time clients, underlines the importance of around-the-clock access, especially for those involved in street-based sex work. Although women make up a smaller percentage of people who inject drugs in Australia [44], they are among the most hidden [45]. They experience significant differences in their health status and injecting-related risk practices compared to men, including an increased likelihood of injection-related injuries and harms, mental health issues and physical and sexual violence [46, 47]. Those who are involved in sex work are at greater risk of sexually transmitted infections and threats of violence that undermine their ability to practice safer sex and drug use, both in contexts with intimate partners and during sex work [45, 47,48,49]. Women who inject drugs are also more likely to experience a greater burden of substance use-related stigma than men, due to gendered social norms [8, 50], which can be a barrier for accessing harm reduction services such as NSPs [45, 49, 51, 52]. As our findings have demonstrated, the St Kilda NSP’s capacity to respond appropriately and non-judgementally to many of the issues described above was considered one of the most important aspects of the services provided for women outside of business hours (e.g. responses to incidents of intimate partner violence, and sexual assault, harassment and violence on the streets; access to injecting equipment and SSE; and the opportunity for safety in the confines of the NSP). Women’s voices and experiences have often been silenced in studies around harm reduction service provision, hampering the development of harm reduction services to meet their specific needs [47, 53]—our study has helped fill this gap by giving voice to disadvantaged women accessing the NSP.

While access and equity are key challenges for the distribution of sterile needles/syringes to people who inject drugs, as demonstrated in this study, more nuanced models of syringe distribution can effectively respond to different time periods of needle/syringe demand and the specific health and well-being needs of disadvantaged sub-populations of people who inject drugs.

Our complimentary use of five data sets allowed us to develop a nuanced and comprehensive understanding of the role and effectiveness of the St Kilda NSP for individuals using the service. By capitalising on the strengths of both quantitative and qualitative methods we believe we have also increased the rigour and credibility of our findings [31].

Limitations

Our study has some limitations. NSPSIS and NSP snapshot data represent service contacts rather than individual participants, and so we cannot accurately profile individual clients. Furthermore, snapshot surveys are subject to recall and social desirability biases, and we recognise that clients who participated in qualitative interviews were selected by staff who work in the NSP and thus may have been positively biased in their view of the service. Finally, we acknowledge that conducting an overall economic cost–benefit analysis of the St Kilda 24/7 NSP would have been beneficial and thus we recommend this occurs in the future.

Conclusion

Our study provides important implications for policy makers and implementers of NSP services. By examining the role and effectiveness of the St Kilda 24/7 primary NSP service model, we have demonstrated that through the provision of after-hours services, so much more can be achieved (beyond the role of preventing the transmission of BBVs), for improving the overall health and well-being of disadvantaged sub-populations of people who inject drugs. Findings support the need for the establishment of 24/7 primary NSPs in other areas of Australia where active street-based drug markets operate and concentrated numbers of people who inject drugs live and spend time.

Availability of data and materials

Study data are not publicly available due to their sensitive nature and the potential for participant identification. Data may be made available for collaborative work subject to permission from the project’s Chief Investigators, including The Salvation Army Territory Australia. Researchers interested in data access should contact the corresponding author (S.W.) to discuss potential collaborations.

Notes

  1. The Ugly Mugs Report is published by St Kilda based “Resourcing Health and Education in the Sex Industry (RhED)” in collaboration with local police, with the aim of alerting sex workers to dangerous individuals in the local area.

References

  1. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6–7):777–813. https://0-doi-org.brum.beds.ac.uk/10.1080/10826080600669579.

    Article  PubMed  Google Scholar 

  2. Carrotte E, Dietze P, Kirwan A. Syringe coverage and Australian NSPs. Melbourne (AUST): Centre for Research Excellence into Injecting Drug Use; 2015. https://creidu.edu.au/system/policy_document/12/pdf/Policy_Brief_Kirwan_Syringe_coverage.pdf.

  3. O’Keefe D, Ritter A, Stoove M, Hughes C, Dietze P. Harm reduction programs and policy in Australia: barriers and enablers to effective implementation. Sucht. 2020;66(1):33–43. https://0-doi-org.brum.beds.ac.uk/10.1024/0939-5911/a000641.

    Article  Google Scholar 

  4. Heard S, Iversen J, Geddes L, Kwon JA, Maher L. Needle syringe program national minimum data collection: 2021 National data report 2021. Sydney (AUST): Kirby Institute; 2021. https://www.kirby.unsw.edu.au/research/projects/ansps.

  5. Sweeney S, Ward Z, Platt L, Guinness L, Hickman M, Hope V, et al. Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction. 2019;114(3):560–70. https://0-doi-org.brum.beds.ac.uk/10.1111/add.14519.

    Article  PubMed  Google Scholar 

  6. Ward Z, Sweeney S, Platt L, Guinness L, Maher L, Hope V, et al. The cost-effectiveness of needle and syringe provision in preventing transmission of Hepatitis C virus in people who inject drugs. J Hepatol. 2018;68:S146–7.

    Article  Google Scholar 

  7. O’Keefe D, Jacka D, Maher L. Changes in needle and syringe presentations point to the successes of Australian harm reduction policy and practice. Aust N Z J Public Health. 2023;47(1): 100016. https://0-doi-org.brum.beds.ac.uk/10.1016/j.anzjph.2022.100016.

    Article  PubMed  Google Scholar 

  8. Watson L, Delhomme F, Mackie B. Needle and syringe programs in NSW: Opportunities for innovation. Sydney (AUST): ACON Health; 2022. https://www.acon.org.au/wp-content/uploads/2022/06/2022-05-2024-ACON-NSP-Policy-paper.pdf.

  9. Treloar C, Cao W. Barriers to use of needle and syringe programmes in a high drug use area of Sydney, New South Wales. Int J Drug Policy. 2005;16(5):308–15. https://0-doi-org.brum.beds.ac.uk/10.1016/j.drugpo.2005.06.005.

    Article  Google Scholar 

  10. Treloar C, Rance J, Yates K, Mao L. Trust and people who inject drugs: the perspectives of clients and staff of Needle Syringe Programs. Int J Drug Policy. 2016;27:138–45. https://0-doi-org.brum.beds.ac.uk/10.1016/j.drugpo.2015.08.018.

    Article  PubMed  Google Scholar 

  11. Cama E, Brener L, Bryant J. Characteristics and attendance patterns of a fixed-site NSP and nearby SVM: the benefits of 24-hour access to sterile injecting equipment. Drugs Educ Prev Policy. 2014;21(6):476–81. https://0-doi-org.brum.beds.ac.uk/10.3109/09687637.2014.956051.

    Article  Google Scholar 

  12. O’Keefe D, Aitken C, Scott N, Dietze P. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: effects on individual-level needle and syringe coverage. Drug Alcohol Depend. 2018;191:259–65. https://0-doi-org.brum.beds.ac.uk/10.1016/j.drugalcdep.2018.07.007.

    Article  PubMed  Google Scholar 

  13. Islam MM, Stern T, Conigrave KM, Wodak A. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. Drug Alcohol Rev. 2008;27(1):13–9. https://0-doi-org.brum.beds.ac.uk/10.1080/09595230701711199.

    Article  PubMed  Google Scholar 

  14. Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S, et al. A scoping review of implementation considerations for harm reduction vending machines. Harm Reduct J. 2023;20(1):33. https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-023-00765-2.

    Article  PubMed  PubMed Central  Google Scholar 

  15. O’Keefe D, Livingston M, Cossar RD, Kerr P, Jacka D, Dietze P. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia. Harm Reduct J. 2022;19(1):101. https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-022-00683-9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Stewart RE, Cardamone NC, Loscalzo E, French R, Lovelace C, Mowenn WK, et al. “There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction. Harm Reduct J. 2023;20(1):1–10. https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-023-00747-4.

    Article  Google Scholar 

  17. Kerr P, Cossar RD, Livingston M, Jacka D, Dietze P, O’Keefe D. Analysis of four syringe dispensing machine point-of-access data 2017–2020 in Melbourne, Australia: machine utilisation and client demographics. Harm Reduct J. 2022;19(1):1–9. https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-022-00726-1.

    Article  Google Scholar 

  18. Walker S, Dietze P, Higgs P, Ward B, Treloar C, Stoové M, et al. Socioeconomic consequences of the COVID-19 pandemic for people who use drugs. Aust J Soc Issues. 2023. https://0-doi-org.brum.beds.ac.uk/10.1002/ajs4.289.

    Article  Google Scholar 

  19. Topp L, Iversen J, Baldry E, Maher L. NSPs Collaboration of Australian NSPs. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013;90:699–716. https://0-doi-org.brum.beds.ac.uk/10.1007/s11524-012-9730-6.

  20. Djordjevic F, Ryan K, Gunn J, Brener L, O’Keefe D, Draper B, et al. Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne. Aust J Viral Hep. 2021;28(12):1738–43. https://0-doi-org.brum.beds.ac.uk/10.1111/jvh.13612.

    Article  Google Scholar 

  21. Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207. https://0-doi-org.brum.beds.ac.uk/10.1016/S2214-109X(17)30375-3.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4(1):1–9. https://0-doi-org.brum.beds.ac.uk/10.1186/1477-7517-4-14.

    Article  Google Scholar 

  23. Islam MM. Needle syringe program-pased primary healthcare centers: advantages and disadvantages. J Prim Care Community Health. 2010;1(2):100–3. https://0-doi-org.brum.beds.ac.uk/10.1177/2150131910369684.

    Article  PubMed  Google Scholar 

  24. Dietze P, Kirwan A, Curtis M, Walker S, Woods E. St Kilda 24 NSP Evaluation. Melbourne (AUST): Centre for Research Excellence into Injecting Drug Use; 2018. https://creidu.edu.au/system/resource/83/file/St_Kilda_24-Hour_NSP_Evaluation_Report_2018.pdf.

  25. Moore D, Dietze P. Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug Alcohol Rev. 2005;24(3):275–84. https://0-doi-org.brum.beds.ac.uk/10.1080/09595230500170258.

    Article  PubMed  Google Scholar 

  26. Shaw KS, Hagemans IW. Gentrification without displacement’and the consequent loss of place: the effects of class transition on low-income residents of secure housing in gentrifying areas. Int J Urban Reg Res. 2015;39(2):323–41. https://0-doi-org.brum.beds.ac.uk/10.1111/1468-2427.12164.

    Article  Google Scholar 

  27. Linton SL, Cooper HL, Kelley ME, Karnes CC, Ross Z, Wolfe ME, et al. Cross-sectional association between ZIP code-level gentrification and homelessness among a large community-based sample of people who inject drugs in 19 US cities. BMJ Open. 2017;7(6): e013823.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kasinitz P. Gentrification and homelessness: the single room occupant and the inner city revival. Housing the homeless: Routledge; 2017. p. 241–52.

    Google Scholar 

  29. Wilson G. Goodbye to the Gatick and to so much of the old St Kilda: The Conversation; 2017. https://theconversation.com/goodbye-to-the-gatwick-and-to-so-much-of-the-old-st-kilda-78681.

  30. Rowe J. A pragmatic exchange: a short history of the health information exchange and the reconciliation of Christian faith and harm reduction. Melbourne (AUST): The Salvation Army Crisis Services; 2013.

  31. Hendren K, Newcomer K, Pandey SK, Smith M, Sumner N. How qualitative research methods can be leveraged to strengthen mixed methods research in public policy and public administration? Public Adm Rev. 2023;83(3):468–85. https://0-doi-org.brum.beds.ac.uk/10.1111/puar.13528.

    Article  Google Scholar 

  32. Department of Health. Needle and Syringe Program Information System (NSPIS). Melbourne (AUST): Victorian Government; 2022. https://www.health.vic.gov.au/funding-and-reporting-aod-services/needle-and-syringe-program-information-system-nspis.

  33. NVivo (released in March 2020), [Internet]. 2020. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home.

  34. Clarke V, Braun V, Hayfield N. Thematic analysis. In: Smith JA editor. Qualitative psychology: a practical guide to research methods, vol. 3. London: SAGE. 2015. p. 222–48.

  35. Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs: principles and practices. Health Serv Res. 2013;48(6pt2):2134–56. https://0-doi-org.brum.beds.ac.uk/10.1111/1475-6773.12117

  36. Hill P, O’Keefe D, Dietze PM. Are there differences in individual-level needle and syringe coverage across Australian jurisdictions related to program policy? A preliminary analysis. Drug Alcohol Rev. 2018;37(5):653–7. https://0-doi-org.brum.beds.ac.uk/10.1111/dar.12821.

    Article  PubMed  Google Scholar 

  37. Treloar C, Hopwood M, Bryant J. ‘Does anyone know where to get fits from around here?’ Policy implications for the provision of sterile injecting equipment through pharmacies in Sydney. Aust Drugs Educ Prev Policy. 2010;17(1):72–83. https://0-doi-org.brum.beds.ac.uk/10.3109/09687630802067251.

    Article  Google Scholar 

  38. van Santen DK, Boyd A, Matser A, Maher L, Hickman M, Lodi S, et al. The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: Findings from an emulated target trial. Addiction. 2021;116(11):3115–26. https://0-doi-org.brum.beds.ac.uk/10.1111/add.15503.

    Article  PubMed  Google Scholar 

  39. Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: A systematic review. Lancet Glob Health. 2017;5(12):e1208–20. https://0-doi-org.brum.beds.ac.uk/10.1016/S2214-109X(17)30373-X.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, et al. Effectiveness of needle and syringe programmes in people who inject drugs: An overview of systematic reviews. BMC Public Health. 2017;17(1):1–15. https://0-doi-org.brum.beds.ac.uk/10.1186/s12889-017-4210-2.

    Article  Google Scholar 

  41. Allen ST, Grieb SM, O’Rourke A, Yoder R, Planchet E, White RH, et al. Understanding the public health consequences of suspending a rural syringe services program: A qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):1–10. https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-019-0305-7.

    Article  Google Scholar 

  42. Islam MM, Shanahan M, Topp L, Conigrave KM, White A, Day CA. The cost of providing primary health-care services from a needle and syringe program: A case study. Drug Alcohol Rev. 2013;32(3):312–9. https://0-doi-org.brum.beds.ac.uk/10.1111/dar.12019.

    Article  PubMed  Google Scholar 

  43. Islam MM, Topp L, Conigrave KM, White A, Reid SE, Grummett S, et al. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. J Subst Abuse Treat. 2012;43(4):440–5. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jsat.2012.07.007.

    Article  PubMed  Google Scholar 

  44. Larney S, Hickman M, Guy R, Grebely J, Dore GJ, Gray RT, et al. Estimating the number of people who inject drugs in Australia. BMC Public Health. 2017;17(1):1–7. https://0-doi-org.brum.beds.ac.uk/10.1186/s12889-017-4785-7.

    Article  Google Scholar 

  45. Azim T, Bontell I, Strathdee SA. Women, drugs and HIV I. J Drug Policy. 2015;26:S16–21. https://0-doi-org.brum.beds.ac.uk/10.1016/j.drugpo.2014.09.003.

    Article  Google Scholar 

  46. Meyers S, Earnshaw V, D’Ambrosio B, Courchesne N, Werb D, Smith L. The intersection of gender and drug use-related stigma: a mixed methods systematic review and synthesis of the literature. Drug Alcohol Depend. 2021;223: 108706. https://0-doi-org.brum.beds.ac.uk/10.1016/j.drugalcdep.2021.108706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Iversen J, Page K, Madden A, Maher L. HIV, HCV and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 1999; 2015;69(1):S176. 10.1097%2FQAI.0000000000000659

  48. Pinkham S, Stoicescu C, Myers B. Developing effective health interventions for women who inject drugs: key areas and recommendations for program development and policy. Adv Prev Med. 2012. https://0-doi-org.brum.beds.ac.uk/10.1155/2012/269123.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Agramunt S, Lenton S. Injecting risk behaviours and harms associated with injecting drug use in Australia: Are there differences by gender? Sydney (AUST): National Drug and Alcohol Research Centre, University of New South Wales Sydney; 2020. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Injecting%20risk%20behaviours%20and%20gender%20differences.pdf.

  50. Iversen J, Grebely J, Topp L, Wand H, Dore G, Maher L. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011. J Viral Hepat. 2014;21(3):198–207. https://0-doi-org.brum.beds.ac.uk/10.1111/jvh.12129.

    Article  CAS  PubMed  Google Scholar 

  51. Jones A, Schneider K, Falade-Nwulia O, Sterner G, Tobin K, Latkin C. Social networks, stigma, and hepatitis C care among women who inject drugs: findings from a community recruited sample. J Psychoact Drugs. 2023;55(4):464–70. https://0-doi-org.brum.beds.ac.uk/10.1080/02791072.2022.2129886.

    Article  CAS  Google Scholar 

  52. Gibson K, Hutton F. Women who inject drugs (WWID): Stigma, gender and barriers to needle exchange programmes (NEPs). Contemp Drug Probl. 2021;48(3):276–96. https://0-doi-org.brum.beds.ac.uk/10.1177/00914509211035242.

    Article  Google Scholar 

  53. Roberts A, Mathers B, Degenhardt L. Women who inject drugs: a review of their risks, experiences and needs. Sydney (AUST): National Drug and Alocohol Research Centre, University of New South Wales; 2010. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Women%20who%20inject%20drugs.pdf.

Download references

Acknowledgements

The authors would like to thank the interview participants who generously shared their experiences and insights for this study. We would like to thank the advisory group (including St Kilda NSP and Salvation Army staff, and representatives from the Victorian Government) who provided project support and input, and Burnet Institute fieldworkers who collected qualitative interview data.

Funding

Burnet Institute receives funding from the Victorian Government Operational Infrastructure Support Program. The project was funded by The Salvation Army Territory Australia.

Author information

Authors and Affiliations

Authors

Contributions

SW collected and analysed the qualitative data and wrote the main manuscript text. MC analysed the quantitative data, prepared the figures/tables, wrote up the quantitative findings and reviewed the manuscript text. PD acquired the funding, conceptualised study design, and reviewed the manuscript text. AK conceptualised study design, administrated the project, and reviewed the manuscript text. RT conceptualised study design, coordinated the project, and reviewed the manuscript text. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shelley Walker.

Ethics declarations

Competing interests

Rebecca Thatcher is employed by The Salvation Army Territory Australia, who funded this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Walker, S., Curtis, M., Kirwan, A. et al. “No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia. Harm Reduct J 21, 51 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-024-00960-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12954-024-00960-9

Keywords